N6-methyladenosine-regulated ADIRF impairs lung adenocarcinoma metastasis and serves as a potential prognostic biomarker.

Cancer Biol Ther · 2023 · PMC10501161 · PMID 37700507

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In contrast to high ADIRF expression in breast cancer, we found that ADIRF showed a trend of low expression in LUAD and ADIRF levels could effectively distinguish cancer individuals from healthy samples.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.